Gladstone scientists report tremendous growth and new developments in WikiPathways, an open-access, open-source repository that has grown from a Gladstone experimental project to a valuable resource for scientists across the globe.
Gladstone established the Assay Development and Drug Discovery Core to help scientists accelerate their research into target and drug-discovery phases and move their findings into clinical trials and potential therapies for disease.
Nobel Prize winner Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes in San Francisco, has been elected to the National Academy of Medicine.
Gladstone has received funding from the National Institutes of Health to continue and expand two exciting projects in cardiovascular research. The funding, totaling more than $6.8 million, supports two teams of scientists and their research on congenital heart disease.
Li Gan, PhD, has been selected to present the Inge Grundke-Iqbal Lecture for Alzheimer’s Research at the Alzheimer’s Association International Conference (AAIC) in Washington, D.C. in July.
The Gladstone Histology and Light Microscopy Core welcomes new staff to revitalize its state-of-the-art services for preparing histological samples and visualizing them with microscopy
The discovery of cell reprogramming by Shinya Yamanaka changed the way scientists see cell biology, but the details of how it works are still being defined. In a recent paper, the labs of Yamanaka and Bruce Conklin show how one key factor—NANOG—is involved in the process.
Collaborations have been key to Gladstone’s scientific success since its founding, and its community believes that the biggest challenges in science are better met by bringing together researchers with diverse backgrounds.
Jeanne Paz, PhD, an assistant investigator at the Gladstone Institutes, has been awarded the prestigious Michael Prize, honoring her significant contributions to the field of epilepsy.
Katerina Akassoglou is working to identify a biomarker that could track the progression of multiple sclerosis using blood tests